A hypodiploid corticotroph pituitary tumor with a germline TP53 variant

Abstract Li-Fraumeni syndrome (LFS), caused by germline TP53 mutations, predisposes to a wide spectrum of malignancies, but an association with pituitary tumors has not been definitively established. We performed germline sequencing on 20 patients with aggressive pituitary tumors. Pathogenic/likely pathogenic variants were identified in three patients: one high-penetrant variant, TP53 (NM_000546) c.799C>T (p.Arg267Trp), and two low-penetrant variants that are likely incidental findings: LZTR1 (NM_006767) c.1214delG (p.Gly405Alafs*56) and MUTYH (NM_001128425) c.536A>G (p.Tyr179Cys). The patient diagnosed with LFS presented in her 20s with an aggressive, silent corticotroph pituitary tumor that progressed within 5 months of the initial subtotal transsphenoidal resection. Molecular analysis identified biallelic inactivation of TP53 and widespread chromosomal loss-of-heterozygosity (cLOH) involving 8 of the 12 chromosomes frequently lost in aggressive corticotroph tumors with somatic TP53 mutations. Biallelic TP53 inactivation and the presence of cLOH supports that the germline TP53 mutation functions as a driver.

Authors

Institutions

Publication Details

Journal
European Journal of Endocrinology
Published
2026-11-13
DOI
https://doi.org/10.1093/ejendo/lvag206
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A hypodiploid corticotroph pituitary tumor with a germline TP53 variant

Andrew L. Lin, Eliza Brevoort Geer, Yanming Zhang, Nikita N. Mehta et al.
European Journal of Endocrinology
Pituitary Gland Disorders and Treatments
article

A hypodiploid corticotroph pituitary tumor with a germline TP53 variant

Andrew L. Lin, Eliza Brevoort Geer, Yanming Zhang, Nikita N. Mehta, Jamal K. Benhamida, Maria Isabel Carlo, Viviane S. Tabar, Angeliki Theodorou, Allison Richards
article en

Abstract

Abstract Li-Fraumeni syndrome (LFS), caused by germline TP53 mutations, predisposes to a wide spectrum of malignancies, but an association with pituitary tumors has not been definitively established. We performed germline sequencing on 20 patients with aggressive pituitary tumors. Pathogenic/likely pathogenic variants were identified in three patients: one high-penetrant variant, TP53 (NM_000546) c.799C>T (p.Arg267Trp), and two low-penetrant variants that are likely incidental findings: LZTR1 (NM_006767) c.1214delG (p.Gly405Alafs*56) and MUTYH (NM_001128425) c.536A>G (p.Tyr179Cys). The patient diagnosed with LFS presented in her 20s with an aggressive, silent corticotroph pituitary tumor that progressed within 5 months of the initial subtotal transsphenoidal resection. Molecular analysis identified biallelic inactivation of TP53 and widespread chromosomal loss-of-heterozygosity (cLOH) involving 8 of the 12 chromosomes frequently lost in aggressive corticotroph tumors with somatic TP53 mutations. Biallelic TP53 inactivation and the presence of cLOH supports that the germline TP53 mutation functions as a driver.

European Journal of Endocrinology
Memorial Sloan Kettering Cancer Center (US)
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon